Category:

12 June 2019

Pharmanutra: sales network evolution and new commercial strategies

05 June 2019

THE INTERNATIONAL EXPANSION OF THE SIDERALĀ® LINE CONTINUES

29 May 2019

NOTIFICATION PURSUANT TO ARTICLE 17 OF THE AIM ITALIA ISSUERS REGULATIONS

27 May 2019

PHARMANUTRA PRESENTE ALLā€™AIM ITALIA CONFERENCE

10 May 2019

CO-OPTATION OF A NEW ADMINISTRATOR

06 May 2019

NEW INTERNATIONAL AGREEMENTS FOR THE CETILARĀ® LINE

23 April 2019

JORDAN JOINS THE PHARMANUTRA PARTNER COUNTRIES

16 April 2019

Notification pursuant to article 17 of the AIM Italia issuers regulations

16 April 2019

New transaction between Shareholders

16 April 2019

Resignation of a Board Member

16 April 2019

Clarification regarding the 2018 dividend

16 April 2019

Shareholders’ Meeting of 15.04.2019

18 March 2019

NEW INTERNATIONAL AGREEMENTS FOR THE DISTRIBUTION OF CETILARĀ® AND ULTRAMAGĀ®

13 March 2019

PHARMANUTRA DRAFT FINANCIAL STATEMENTS AND CONSOLIDATED FINANCIAL STATEMENTS AT 31.12.2018

12 March 2019

THE 7TH EDITION OF THE INTERNATIONAL MULTIDISCIPLINARY COURSE ON IRON DEFICIENCY IN ROME

21 February 2019

PHARMANUTRA SIGNS TWO NEW AGREEMENTS FOR THE DISTRIBUTION OF SUCROSOMIAL IRON IN GREECE AND UKRAINE

15 January 2019

PHARMANUTRA SIGNS AN AGREEMENT WITH TRIGEN PHARMA INTERNATIONAL FOR THE DISTRIBUTION OF SIDERALĀ® PRODUCTS IN PAKISTAN

10 January 2019

PHARMANUTRA: CORPORATE EVENTS CALENDAR 2019

20 December 2018

PHARMANUTRA SIGNS AN IMPORTANT AGREEMENT TO DISTRIBUTE THE CETILARĀ® LINE IN THAILAND, OPENING UP THE SOUTH EAST ASIAN MARKET

14 December 2018

AIM ITALY: PHARMANUTRA IN THE TOP 10 FOR PERFORMANCE AND CAPITALISATION

10 December 2018

NEW AREAS OF APPLICATION RECOGNISED FOR SUCROSOMIAL IRON

1 … 8 9 10 11
Modifica preferenze Cookie
Modifica preferenze Cookie